FDA — authorised 12 February 2004
- Application: BLA125084
- Marketing authorisation holder: IMCLONE
- Local brand name: ERBITUX
- Indication: VIAL — INTRAVENOUS
- Status: approved
🇺🇸 Cetuximab injection in United States
FDA authorised Cetuximab injection on 12 February 2004
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Cetuximab injection approved in United States?
Yes. FDA authorised it on 12 February 2004.
Who is the marketing authorisation holder for Cetuximab injection in United States?
IMCLONE holds the US marketing authorisation.